共 50 条
- [1] The DPP-4 inhibitor, LAF237, improves glycemic control in patients with type 2 diabetes (T2DM) inadequately treated with metformin[J]. DIABETES, 2004, 53 : A83 - A83Ahren, BGomis, RMills, DSchweizer, A
- [2] Addition of sitagliptin to pioglitazone improved glycemic control with neutral weight effect over 24 weeks in inadequately controlled type 2 diabetes (T2DM)[J]. DIABETES, 2006, 55 : A132 - A133Rosenstock, JulioBrazg, RonaldAndryuk, Paula J.Sisk, Christine McCraryLu, KaifengStein, Peter
- [3] Sitagliptin added to ongoing treatment with metformin improved glycemic control and was well tolerated in Japanese patients with type 2 diabetes (T2DM)[J]. DIABETES, 2008, 57 : A589 - A590Kadowaki, TakashiTajima, NaokoOdawara, MasatoNishii, MikioNonaka, KenjiStein, Peter P.
- [4] Inhaled insulin provides improved glycemic control in patients with type 2 diabetes mellitus inadequately controlled with oral agents - A randomized controlled trial[J]. ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (19) : 2277 - 2282Weiss, SRCheng, SLKourides, IAGelfand, RALandschulz, WH
- [5] Empagliflozin as Add-On to Metformin for 24 Weeks Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)[J]. DIABETES, 2013, 62 : A282 - A282Haering, Hans-UlrichMerker, LudwigSeewaldt-Becker, ElkeWeimer, MarcMeinicke, ThomasBroedl, Uli C.Woerle, Hans J.
- [6] Empagliflozin as Add-On to Pioglitazone With or Without Metformin Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)[J]. DIABETES, 2013, 62 : A291 - A291Kovacs, ChristopherSeshiah, VeeraswamySwallow, RosJones, RussellRattunde, HenningWoerle, Hans J.Broedl, Uli C.
- [7] Glucose-Lowering Effects of an Oral Glucokinase (GK) Activator, MK-0941, in Patients with Type 2 Diabetes (T2DM) Inadequately Controlled by Metformin[J]. DIABETES, 2011, 60 : A608 - A608O'Neill, Edward A.Migoya, ElizabethMiller, JuttaMoreau, MeghanMaganti, LataLarson, PatrickGutierrez, MariaDenoia, EmanuelWagner, John A.Stoch, Aubrey
- [8] Change in lipid variables with insulin glargine versus pioglitazone in T2DM patients inadequately controlled on a sulfonylurea or metformin[J]. DIABETOLOGIA, 2007, 50 : S506 - S506McGill, J. B.Traylor, L.Dwarakanathan, A.
- [9] Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study[J]. PEERJ, 2020, 8Du, GuoliXie, WanrunSu, YinxiaMa, YaoGao, XiaomingJiang, ShengLiang, Huazheng
- [10] Efficacy and Safety of Saxagliptin Add-on to Metformin Compared with Acarbose Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin Monotherapy[J]. DIABETES, 2016, 65 : A293 - A293Du, JinLiang, LiFang, HuiXu, FengmeiLi, WeiShen, LiyaMu, Yiming